Literature DB >> 32473910

Early vs Late Discharge in Low-Risk ST-Elevation Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.

Zain Ul Abideen Asad1, Safi U Khan2, Amod Amritphale3, Adhir Shroff4, Kusum Lata5, Arnold H Seto6, Muhammad Shahzeb Khan7, Sunil V Rao8, Mazen Abu-Fadel3.   

Abstract

BACKGROUND: For low-risk patients with ST-elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI) the recommended optimal discharge timing is inconsistent in guidelines. The European Society of Cardiology guidelines recommend early discharge within 48-72 h, while the American College of Cardiology guidelines do not recommend a specific discharge strategy. In this systematic review and meta-analysis we compared outcomes with early discharge (≤3 days) versus late discharge (>3 days).
METHODS: Randomized controlled trials (RCTs) and observational studies were selected after searching MEDLINE and EMBASE database. Meta-analysis was stratified according to study design. Outcomes were reported as random effects risk ratios (RR) with 95% confidence intervals.
RESULTS: Seven RCTs comprising 1780 patients and 4 observational studies comprising 39,288 patients were selected. The RCT-restricted analysis did not demonstrate significant differences in terms of all-cause mortality (RR, 0.97 [0.23-4.05]) and major adverse cardiac events (MACE) (RR, 0.84 [0.56-1.26]). Conversely, observational study restricted analysis showed that early vs late discharge strategy was associated with a reduction in all-cause mortality (RR, 0.40 [0.23-0.71]) and MACE (RR, 0.45 [0.26-0.78]). There were no significant differences in hospital readmissions between early vs late discharge in both RCT or observational study analyses.
CONCLUSIONS: Early discharge strategy in appropriately selected low-risk patients with STEMI undergoing PCI is safe and it has the potential to improve cost of care.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Length of stay; Meta-analysis; ST-elevation myocardial infarction

Mesh:

Year:  2020        PMID: 32473910      PMCID: PMC7988891          DOI: 10.1016/j.carrev.2020.04.030

Source DB:  PubMed          Journal:  Cardiovasc Revasc Med        ISSN: 1878-0938


  31 in total

1.  Safety and health status following early discharge in patients with acute myocardial infarction treated with primary PCI: a randomized trial.

Authors:  Tor Melberg; Marianne Jørgensen; Stein Ørn; Torhild Solli; Unni Edland; Kenneth Dickstein
Journal:  Eur J Prev Cardiol       Date:  2014-11-14       Impact factor: 7.804

2.  Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction.

Authors:  C L Grines; D L Marsalese; B Brodie; J Griffin; B Donohue; C R Costantini; C Balestrini; G Stone; T Wharton; P Esente; M Spain; J Moses; M Nobuyoshi; M Ayres; D Jones; D Mason; D Sachs; L L Grines; W O'Neill
Journal:  J Am Coll Cardiol       Date:  1998-04       Impact factor: 24.094

3.  Trends in door-to-balloon time and mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Anneliese Flynn; Mauro Moscucci; David Share; Dean Smith; Thomas LaLonde; Hameem Changezi; Arthur Riba; Hitinder S Gurm
Journal:  Arch Intern Med       Date:  2010-11-08

Review 4.  Safety of early discharge after primary angioplasty in low-risk patients with ST-segment elevation myocardial infarction: A meta-analysis of randomised controlled trials.

Authors:  Wei Gong; Aobo Li; Hui Ai; Han Shi; Xiao Wang; Shaoping Nie
Journal:  Eur J Prev Cardiol       Date:  2018-03-14       Impact factor: 7.804

5.  What is the optimal length of stay in hospital for ST elevation myocardial infarction treated with primary percutaneous coronary intervention?

Authors:  Ahmet Karabulut; Mahmut Cakmak; Bulent Uzunlar; Ahmet Bilici
Journal:  Cardiol J       Date:  2011       Impact factor: 2.737

6.  Feasibility and safety of an early discharge strategy after low-risk acute myocardial infarction treated with primary percutaneous coronary intervention: the EDAMI pilot trial.

Authors:  Lorenzo Azzalini; Eduard Solé; Jordi Sans; Montserrat Vila; Albert Durán; Dolores Gil-Alonso; Miquel Santaló; Xavier Garcia-Moll; Alessandro Sionis
Journal:  Cardiology       Date:  2015-01-21       Impact factor: 1.869

7.  Next day discharge after successful primary angioplasty for acute ST elevation myocardial infarction. An open randomized study "Prague-5".

Authors:  Radovan Jirmár; Petr Widimský; Jan Capek; Ota Hlinomaz; Ladislav Groch
Journal:  Int Heart J       Date:  2008-11       Impact factor: 1.862

8.  Safety of early discharge in low risk patients after acute ST-segment elevation myocardial infarction, treated with primary percutaneous coronary intervention. Open label, randomized trial.

Authors:  Kamil Novobilsky; Roman Stipal; Petr Cerny; Ivo Horak; Vladimir Kaucak; Jan Mrozek; Jan Vaclavik; Radim Kryza
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2018-08-28       Impact factor: 1.245

9.  Safety and feasibility of early hospital discharge in ST-segment elevation myocardial infarction--a prospective and randomized trial in low-risk primary percutaneous coronary intervention patients (the Safe-Depart Trial).

Authors:  Mark A Kotowycz; Tammy L Cosman; Corinne Tartaglia; Rizwan Afzal; Renu Pal Syal; Madhu K Natarajan
Journal:  Am Heart J       Date:  2010-01       Impact factor: 4.749

10.  Acute and 1-Year Hospitalization Costs for Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention: Results From the TRANSLATE-ACS Registry.

Authors:  Patricia A Cowper; J David Knight; Linda Davidson-Ray; Eric D Peterson; Tracy Y Wang; Daniel B Mark
Journal:  J Am Heart Assoc       Date:  2019-04-16       Impact factor: 5.501

View more
  1 in total

1.  Safety and Feasibility of 48 h Discharge After Successful Primary Percutaneous Coronary Intervention.

Authors:  Nooraldaem Yousif; Tarique S Chachar; Suddharsan Subbramaniyam; Vinayak Vadgaonkar; Husam A Noor
Journal:  J Saudi Heart Assoc       Date:  2021-04-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.